Blake Aftab - Oct 12, 2021 Form 3/A - Amendment Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Scientific Officer
Signature
/s/ Nick Harvey, as Attorney-in-Fact
Stock symbol
ACET
Transactions as of
Oct 12, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
10/14/2021, 05:15 PM
Date Of Original Report
Oct 13, 2021
Next filing
Jan 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACET Stock Option (Right to Buy) Oct 12, 2021 Common Stock 50K $15.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest on the first anniversary of April 5, 2021 (the "Vesting Commencement Date") and as to the remaining 75% of such shares in thirty-six (36) equal monthly installments following the first anniversary of the Vesting Commencement Date; provided that the option holder remains continuously engaged by the Company on each such date.

Remarks:

This Form 3/A is being filed to include Exhibit 24, a Power of Attorney for the Reporting Person, which was inadvertently omitted from the original Form 3 filing on October 13, 2021. Exhibit: Power of Attorney